NCT03298568View on ClinicalTrials.gov

Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 21, 2017

Primary Completion Date

December 6, 2017

Study Completion Date

April 16, 2018

Conditions

Food IntoleranceHistamine Intolerance

Interventions

DIETARY_SUPPLEMENT

DAOsin

DAOsin is a food supplement for special medical purpose for the treatment of food intolerance provoked by histamine intake.

Trial Locations (1)

8600

Ordination für Innere Medizin und Stoffwechselzentrum, Bruck an der Mur

All Listed Sponsors

lead

Sciotec Diagnostic Technologies GmbH

INDUSTRY

NCT03298568 - Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity | Biotech Hunter | Biotech Hunter